Literature DB >> 2317954

The identification of a neutral glycosphingolipid antigenic marker for metastatic cells in the R3230AC rat mammary adenocarcinoma.

S A Carlsen1, M Barry, K Newton.   

Abstract

The process of metastasis is a complex process involving numerous steps, and it is thought that cells able to complete all of these steps and form metastatic foci form a unique subpopulation of cells within the tumor. To study this metastatic subpopulation, a marker for the metastatic cells is required. We have previously described the enrichment of soybean agglutinin binding cells in tumor populations enriched for lymphatic metastasis [1]. In this study we provide evidence that the cell-surface structure binding soybean agglutinin is a neutral glycosphingolipid. Using monoclonal antibodies generated against this glycolipid, highly metastatic tumor populations were depleted of cells containing this glycolipid. These depleted cell populations were found to be equally tumorigenic to that of the untreated population but were much less metastatic. These results suggest that this glycolipid may be a useful marker for metastatic cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317954     DOI: 10.1007/bf00117787

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  20 in total

1.  BIOCHEMICAL AND MORPHOLOGIC PROPERTIES OF A NEW LACTATING MAMMARY TUMOR LINE IN THE RAT.

Authors:  R HILF; I MICHEL; C BELL; J J FREEMAN; A BORMAN
Journal:  Cancer Res       Date:  1965-04       Impact factor: 12.701

2.  A new, sensitive determination of phosphate.

Authors:  H Eibl; W E Lands
Journal:  Anal Biochem       Date:  1969-07       Impact factor: 3.365

3.  Involvement of soybean agglutinin binding cells in the lymphatic metastasis of the R3230AC rat mammary adenocarcinoma.

Authors:  N D Buckley; S A Carlsen
Journal:  Cancer Res       Date:  1988-03-15       Impact factor: 12.701

4.  Involvement of plasminogen activator production with tumor metastasis in a rat model.

Authors:  S A Carlsen; I A Ramshaw; R C Warrington
Journal:  Cancer Res       Date:  1984-07       Impact factor: 12.701

Review 5.  Gangliosides: structure, isolation, and analysis.

Authors:  R W Ledeen; R K Yu
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

6.  Dynamic heterogeneity and metastasis.

Authors:  V Ling; A F Chambers; J F Harris; R P Hill
Journal:  J Cell Physiol Suppl       Date:  1984

Review 7.  Generation of phenotypic diversity and progression in metastatic tumor cells.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

8.  Therapy of mouse lymphoma with monoclonal antibodies to glycolipid: selection of low antigenic variants in vivo.

Authors:  W W Young; S I Hakomori
Journal:  Science       Date:  1981-01-30       Impact factor: 47.728

9.  Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

Authors:  P O Livingston; E J Natoli; M J Calves; E Stockert; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

10.  Quantitative isolation of total glycosphingolipids from animal cells.

Authors:  T Saito; S I Hakomori
Journal:  J Lipid Res       Date:  1971-03       Impact factor: 5.922

View more
  4 in total

1.  Identification of differentially expressed genes in isogenic highly metastatic and poorly metastatic cell lines of R3230AC rat mammary adenocarcinoma.

Authors:  H Günes; S A Carlsen
Journal:  Cell Prolif       Date:  2003-12       Impact factor: 6.831

Review 2.  Adhesion mechanisms in lymphatic metastasis.

Authors:  P Brodt
Journal:  Cancer Metastasis Rev       Date:  1991-05       Impact factor: 9.264

3.  CREB3L1 is a metastasis suppressor that represses expression of genes regulating metastasis, invasion, and angiogenesis.

Authors:  Paul Mellor; Leah Deibert; Brian Calvert; Keith Bonham; Svein A Carlsen; Deborah H Anderson
Journal:  Mol Cell Biol       Date:  2013-10-14       Impact factor: 4.272

Review 4.  Tumor progression: potential role of unstable genomic changes.

Authors:  R P Hill
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.